4:10 PM ET
8-K
Loan & Debt
Northwest Biotherapeutics $5.5M Debt Financing with Streeterville Capital, LLC
Northwest Biotherapeutics entered into a $5.505 million commercial loan agreement and note with Streeterville Capital, LLC. The loan carries an 8% annual interest rate, a 10% original issue discount, and a 22-month maturity with no repayments required for the first 8 months. Proceeds will be used to fund the company's ongoing business operations.
- Value
- $5.5M
- Counterparty
- Streeterville Capital, LLC
- Term
- 22 months